- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00628836
Treatment of Shoulder Subluxation in Chronic Stroke Patients
BION Implantable Microstimulation System
Study Overview
Detailed Description
The BION™ is a novel implantable neuromuscular stimulator whose intended use in this study is to reanimate the shoulder muscles of stroke survivors with shoulder subluxation. Strokes are considered to be the most important cause of adult disability in North America, with 500,000 new cases per year in the U.S. (National Stroke Association) and 45,000 in Canada (Langton-Hewer, 1990; Shuaib & Hachinski, 1991). Three-quarters of these patients survive and half of the survivors have substantial muscle weakness after 6 months (Gresham et al., 1979) with little chance of spontaneous recovery (Anderson, 1990; Bonita & Beaglehole, 1988). The most commonly affected region in the early phases of recovery is the shoulder; 80% of hemiplegic stroke patients suffer from shoulder subluxation and associated chronic pain (Smith et al., 1980). The shoulder muscles that are normally active tonically are flaccidly paralyzed; the weight of the pendant arm gradually stretches and damages the atrophic muscles and ligaments, allowing the head of the humerus to descend out of the glenoid fossa. This results in chronic shoulder pain that is difficult to treat and tends to obstruct physical therapy directed toward regaining some use of the paretic arm. Our hypothesis is that electrical stimulation delivered by the BIONs should be fundamentally equivalent to muscle activation achieved voluntarily or by transcutaneous electrical nerve stimulation (TENS), but that the BIONs will prove to be a more clinically acceptable and effective approach. The BION system consists of the BION implants themselves, a controller that is operated by the study participant, and fitting hardware and software used by the clinician to implant, test, and program BION function.
In this study, the BION will be used to reanimate the shoulder muscles of stroke survivors experiencing shoulder subluxation. The objective of this study is to evaluate the safety and efficacy of intramuscular stimulation of BIONs to correct established, symptomatic shoulder subluxation in chronic stroke survivors. The results of intramuscular stimulation by BIONs will be compared with the results of treatment with conventional therapy: surface stimulation.
Degree of shoulder subluxation will be the primary outcome measure for the study. We have included other (secondary) outcome measures (i.e., muscle strength, range of motion, functional activity, spasticity/tone, subject satisfaction and pain) which may reveal secondary benefits of treatment with BIONs. The investigation is expected to last up to 21 weeks for each study participant. The study will be completed over a 5-year period.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
California
-
Downey, California, United States, 90242
- Rancho Los Angeles National Rehabilitation Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:1.
- Diagnosis of hemiplegic stroke at least 6 months prior to enrollment;
- Paresis of the shoulder muscles;
- Shoulder subluxation (i.e., a positive sulcus sign of 5 mm or more);
- Age 18 years or older;
- Stable use of pain medication for at least one month prior to enrollment;
- Medically stable;
- Able to travel to the testing center;
- Mentally capable to understand and carry out the procedures and communicate concerns; and
- Willing to participate and provide informed consent.
Exclusion Criteria:
- Pregnant, nursing, or planning to become pregnant within the next four months;
- Presence of electronic implants (e.g., cardiac pacemaker, cochlear implant, neurostimulator, etc.);
- Presence of metallic implants in the immediate field of the magnetic coil:
- Use of using electrical stimulation for treatment of their subluxed shoulder in the past month;
- Inability to recruit muscles through surface electrical stimulation because of excessive adipose tissue;
- Presence of other unrelated shoulder problems;
- Severe hemineglect ( patient is unable to acknowledge or answer questions about the involved limb)
- Cancer or other serious illness, including a disease other then stroke resulting in dysfunction of movement.
- Subject is currently enrolled in another clinical trial or research study that involves therapy or intervention to the upper limb.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: SE group
surface stimulation
|
The study will have two phases, each with a six week duration. During phase 1, the BION group will be implanted with BIONs in the middle deltoid and supraspinatus muscles. The muscles will be stimulated electrically by way of the BION and an external controller for one to two hours per day at 5pps in an on-off duty cycle train. The SE group will begin surface stimulation similar to that of BE group. Subjects in either group whose initial therapy in phase 1 successfully reduces the amount of shoulder subluxation to 5mm or less will go off stimulation for six weeks, and be reassessed whether subluxation is redeveloping. If a subject in either group does not respond sufficiently to phase 1 therapy, the participant will move to phase 2 where the shoulder will be stimulated at up to 25 pps either with surface stimulation (SE group) or BION stimulation (BE group) for another six weeks. At the end of phase 2, participants will go off stimulation for six weeks and then be reevaluated. |
Experimental: BE group
BION stimulation
|
The study will have two phases, each with a six week duration. During phase 1, the BION group will be implanted with BIONs in the middle deltoid and supraspinatus muscles. The muscles will be stimulated electrically by way of the BION and an external controller for one to two hours per day at 5pps in an on-off duty cycle train. The SE group will begin surface stimulation similar to that of BE group. Subjects in either group whose initial therapy in phase 1 successfully reduces the amount of shoulder subluxation to 5mm or less will go off stimulation for six weeks, and be reassessed whether subluxation is redeveloping. If a subject in either group does not respond sufficiently to phase 1 therapy, the participant will move to phase 2 where the shoulder will be stimulated at up to 25 pps either with surface stimulation (SE group) or BION stimulation (BE group) for another six weeks. At the end of phase 2, participants will go off stimulation for six weeks and then be reevaluated. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Degree of shoulder subluxation by x-ray
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lucinda Baker, M.D., University of Southern California
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BT3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Shoulder Dislocation
-
Keller Army Community HospitalRecruitingSurgery | Anterior Shoulder Dislocation | Shoulder Subluxation | Recurrent Shoulder DislocationUnited States
-
University of PittsburghWalter Reed National Military Medical CenterRecruitingShoulder Dislocation | Anterior Shoulder Dislocation | Glenohumeral DislocationUnited States
-
Istituto Ortopedico RizzoliRecruitingShoulder Instability | Anterior Shoulder Dislocation | Bone DefectsItaly
-
Carolyn M HettrichUniversity of Colorado, Denver; Washington University School of Medicine; University... and other collaboratorsRecruitingOther Instability, Shoulder | Dislocations | Subluxations | Recurrent Dislocation of Shoulder RegionUnited States
-
Peking University Third HospitalCompletedShoulder; Dislocation, ChronicChina
-
Copenhagen University Hospital, HvidovreCompletedAnterior Shoulder Dislocation
-
Tel-Aviv Sourasky Medical CenterUnknownAnterior Shoulder Dislocation
-
National Taiwan University HospitalUnknownShoulder Anterior DislocationTaiwan
-
Centre Hospitalier Universitaire de NiceRecruitingAnterior Shoulder DislocationFrance
-
Fowler Kennedy Sport Medicine ClinicThe Physicians' Services Incorporated Foundation; American Shoulder and Elbow...CompletedAnterior Shoulder DislocationCanada
Clinical Trials on BION stimulation
-
University of Southern CaliforniaCompleted
-
Boston Scientific CorporationCompletedUrinary IncontinenceUnited States
-
University of Southern CaliforniaCompleted
-
University of Southern CaliforniaWithdrawn
-
Boston Scientific CorporationCompletedOveractive BladderUnited States
-
Boston Scientific CorporationCompletedChronic, Medically Refractory HeadacheUnited States
-
University of Southern CaliforniaCompleted
-
Boston Scientific CorporationCompleted
-
Boston Scientific CorporationCompleted
-
Chinook Therapeutics, Inc.Active, not recruitingIgA NephropathyKorea, Republic of, United States, United Kingdom